U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06892418) titled 'Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: a Clinical Study' on March 21.
Brief Summary: This study aims to investigate the effects of the Ketoflex 12/3 diet on motor and non-motor symptoms in patients with Parkinson's disease. Participants will follow the Ketoflex 12/3 dietary regimen, and their cognitive function, motor symptoms, sleep patterns, gastrointestinal health, and overall well-being will be assessed through standardized clinical scales. The study will help determine whether a plant-based ketogenic diet combined with intermittent fasting can have a beneficial impact on Parkinson's disease progression....